BioRestorative Therapies, Inc. (OTCMKTS:BRTX – Get Free Report)’s stock price crossed below its 50 day moving average during trading on Friday . The stock has a 50 day moving average of $0.99 and traded as low as $0.2121. BioRestorative Therapies shares last traded at $0.2185, with a volume of 6,484,643 shares traded.
BioRestorative Therapies Stock Performance
The firm has a 50 day moving average price of $0.99 and a two-hundred day moving average price of $1.28. The company has a market capitalization of $1.98 million, a P/E ratio of -0.15 and a beta of 0.39.
BioRestorative Therapies Company Profile
BioRestorative Therapies, Inc (OTCMKTS:BRTX) is a clinical-stage biotechnology company dedicated to developing regenerative medicine therapies for urological, orthopedic and rehabilitative indications. The company’s research focuses on autologous and allogeneic cell therapy platforms designed to repair, regenerate and restore normal tissue function through targeted cell delivery and expansion technologies.
Among its lead programs is BRTX-100, an investigational autologous muscle cell therapy aimed at treating stress urinary incontinence, which is advancing through late-stage clinical studies.
Read More
- Five stocks we like better than BioRestorative Therapies
- Unlocked: Elon Musk’s Next Big IPO
- America’s 1776 happening again
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
- How a Family Trust May Be Able To Help Preserve Your Wealth
- The gold chart Wall Street is terrified of…
Receive News & Ratings for BioRestorative Therapies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioRestorative Therapies and related companies with MarketBeat.com's FREE daily email newsletter.
